Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials

The diagnosis of brain tumors typically relies on magnetic resonance imaging (MRI), computed tomography (CT), and invasive procedures like biopsies or surgical resection for confirmation and genetic profiling. However, these methods have limitations, especially in distinguishing treatment effects li...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Izhar, Abhimanyu Thakur, David J. Park, Steven D. Chang
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:The Journal of Liquid Biopsy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950195424001437
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850123297544470528
author Muhammad Izhar
Abhimanyu Thakur
David J. Park
Steven D. Chang
author_facet Muhammad Izhar
Abhimanyu Thakur
David J. Park
Steven D. Chang
author_sort Muhammad Izhar
collection DOAJ
description The diagnosis of brain tumors typically relies on magnetic resonance imaging (MRI), computed tomography (CT), and invasive procedures like biopsies or surgical resection for confirmation and genetic profiling. However, these methods have limitations, especially in distinguishing treatment effects like pseudo-progression from actual tumor progression, and repeated biopsies pose risks. Liquid biopsy (LB) offers a non-invasive alternative, detecting tumor-derived biomarkers in blood and cerebrospinal fluid (CSF). Despite its potential, the low concentration of brain tumor biomarkers in blood due to the blood-brain barrier (BBB), limits the clinical utility of LB. MRI-guided focused ultrasound (MRgFUS) combined with microbubbles provides a novel solution by temporarily disrupting the BBB, facilitating the passage of therapeutic agents, and enabling tumor biomarker detection. This technique, termed “sonobiopsy,” enables non-invasive biomarker collection for liquid biopsy, potentially improving brain tumor diagnosis and monitoring.
format Article
id doaj-art-83f09797a52946e8bacf1cd802829da4
institution OA Journals
issn 2950-1954
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series The Journal of Liquid Biopsy
spelling doaj-art-83f09797a52946e8bacf1cd802829da42025-08-20T02:34:38ZengElsevierThe Journal of Liquid Biopsy2950-19542024-12-01610027710.1016/j.jlb.2024.100277Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trialsMuhammad Izhar0Abhimanyu Thakur1David J. Park2Steven D. Chang3Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USADepartment of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USADepartment of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA; Corresponding author. Department of Neurosurgery, Stanford University School of Medicine, 453 Quarry Rd, Palo Alto, CA, 94304, USA.Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USAThe diagnosis of brain tumors typically relies on magnetic resonance imaging (MRI), computed tomography (CT), and invasive procedures like biopsies or surgical resection for confirmation and genetic profiling. However, these methods have limitations, especially in distinguishing treatment effects like pseudo-progression from actual tumor progression, and repeated biopsies pose risks. Liquid biopsy (LB) offers a non-invasive alternative, detecting tumor-derived biomarkers in blood and cerebrospinal fluid (CSF). Despite its potential, the low concentration of brain tumor biomarkers in blood due to the blood-brain barrier (BBB), limits the clinical utility of LB. MRI-guided focused ultrasound (MRgFUS) combined with microbubbles provides a novel solution by temporarily disrupting the BBB, facilitating the passage of therapeutic agents, and enabling tumor biomarker detection. This technique, termed “sonobiopsy,” enables non-invasive biomarker collection for liquid biopsy, potentially improving brain tumor diagnosis and monitoring.http://www.sciencedirect.com/science/article/pii/S2950195424001437SonobiopsyLiquid biopsyFocused ultrasoundFUS-Mediated liquid biopsyMicrobubblesBBB opening
spellingShingle Muhammad Izhar
Abhimanyu Thakur
David J. Park
Steven D. Chang
Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials
The Journal of Liquid Biopsy
Sonobiopsy
Liquid biopsy
Focused ultrasound
FUS-Mediated liquid biopsy
Microbubbles
BBB opening
title Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials
title_full Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials
title_fullStr Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials
title_full_unstemmed Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials
title_short Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials
title_sort ultrasound mediated blood brain barrier opening increases brain tumor biomarkers a review of preclinical and clinical trials
topic Sonobiopsy
Liquid biopsy
Focused ultrasound
FUS-Mediated liquid biopsy
Microbubbles
BBB opening
url http://www.sciencedirect.com/science/article/pii/S2950195424001437
work_keys_str_mv AT muhammadizhar ultrasoundmediatedbloodbrainbarrieropeningincreasesbraintumorbiomarkersareviewofpreclinicalandclinicaltrials
AT abhimanyuthakur ultrasoundmediatedbloodbrainbarrieropeningincreasesbraintumorbiomarkersareviewofpreclinicalandclinicaltrials
AT davidjpark ultrasoundmediatedbloodbrainbarrieropeningincreasesbraintumorbiomarkersareviewofpreclinicalandclinicaltrials
AT stevendchang ultrasoundmediatedbloodbrainbarrieropeningincreasesbraintumorbiomarkersareviewofpreclinicalandclinicaltrials